United States Biotechnology & Medical Research

Achaogen Inc (AKAOQ)

Track

Ticker: AKAOQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
DUGGAN ROBERT W
1 sale — total 26,500 USD
Sale 20 Mar 2019
Value US$2,271,573.25 | Price 88.06 | Shares 37,632
Sale 19 Mar 2019
Value US$714,007.72 | Price 349.54 | Shares 71,163
Sale 18 Mar 2019
Value US$152,252.24 | Price 0.56 | Shares 271,879
Sale 13 Mar 2019
Value US$707,958.70 | Price 0.59 | Shares 1,199,930
Sale 12 Mar 2019
Value US$386,724.75 | Price 0.61 | Shares 633,975
Sale 11 Mar 2019
Value US$327,664.26 | Price 0.63 | Shares 520,102
Sale 21 Feb 2019
Value US$864.19 | Price 0.89 | Shares 971
Sale 21 Feb 2019
Value US$946.07 | Price 0.89 | Shares 1,063
Sale 21 Feb 2019
Value US$3,356.19 | Price 0.89 | Shares 3,771
Sale 21 Feb 2019
Value US$703.99 | Price 0.89 | Shares 791
Sale 21 Feb 2019
Value US$1,235.32 | Price 0.89 | Shares 1,388
Sale 5 Feb 2019
Value US$1,104.30 | Price 1.35 | Shares 818
Buy 11 Dec 2018
Value US$505,010.44 | Price 1.65 | Shares 306,848
Buy 10 Dec 2018
Value US$697,788.90 | Price 1.60 | Shares 436,500
Buy 7 Dec 2018
Value US$31,394.43 | Price 1.40 | Shares 22,431
Buy 27 Nov 2018
Value US$129,962.63 | Price 1.68 | Shares 77,585
Buy 23 Nov 2018
Value US$151,643.00 | Price 1.89 | Shares 80,175
Buy 20 Nov 2018
Value US$446,947.40 | Price 1.93 | Shares 231,495
Buy 19 Nov 2018
Value US$7,524.65 | Price 1.62 | Shares 4,648
Sale 25 Sep 2018
Value US$4,307.70 | Price 4.15 | Shares 1,038
Sale 25 Sep 2018
Value US$13,454.30 | Price 4.15 | Shares 3,242
Planned sale 26 Jun 2018
Value US$4,315.50 | Price 9.59 | Shares 450
Planned sale 26 Jun 2018
Value US$11,450.46 | Price 9.59 | Shares 1,194
Planned sale 26 Jun 2018
Value US$7,134.96 | Price 9.59 | Shares 744
Planned sale 26 Jun 2018
Value US$3,107.16 | Price 9.59 | Shares 324
Sale 26 Jun 2018
Value US$2,857.82 | Price 9.59 | Shares 298
Planned sale 11 Jun 2018
Value US$24,939.65 | Price 11.95 | Shares 2,087
Buy 3 May 2018
Value US$1,146,315.67 | Price 11.43 | Shares 100,255
Buy 3 May 2018
Value US$346,338.00 | Price 11.54 | Shares 30,000
Buy 3 May 2018
Value US$9,579,477.21 | Price 11.31 | Shares 846,625
Buy 27 Apr 2018
Value US$1,333,159.59 | Price 12.96 | Shares 102,849
Buy 26 Apr 2018
Value US$647,755.00 | Price 12.96 | Shares 50,000
Buy 25 Apr 2018
Value US$1,005,949.06 | Price 13.02 | Shares 77,247
Buy 23 Apr 2018
Value US$1,730,969.15 | Price 13.07 | Shares 132,487
Buy 20 Apr 2018
Value US$2,860,421.02 | Price 13.23 | Shares 216,150
Buy 19 Apr 2018
Value US$1,527,264.27 | Price 12.76 | Shares 119,700
Buy 4 Apr 2018
Value US$588,976.66 | Price 12.44 | Shares 47,361
Buy 3 Apr 2018
Value US$300,240.21 | Price 12.46 | Shares 24,100
Buy 2 Apr 2018
Value US$250,202.00 | Price 12.51 | Shares 20,000
Buy 28 Mar 2018
Value US$373,095.00 | Price 12.44 | Shares 30,000
Buy 20 Mar 2018
Value US$277,155.00 | Price 11.09 | Shares 25,000
Buy 19 Mar 2018
Value US$126,556.61 | Price 11.20 | Shares 11,300
Buy 15 Mar 2018
Value US$336,756.00 | Price 11.23 | Shares 30,000
Buy 14 Mar 2018
Value US$227,487.83 | Price 11.57 | Shares 19,660
Sale 13 Mar 2018
Value US$32,108.90 | Price 11.74 | Shares 2,735
Buy 12 Mar 2018
Value US$227,802.00 | Price 11.39 | Shares 20,000
Buy 9 Mar 2018
Value US$570,520.00 | Price 11.41 | Shares 50,000
Buy 2 Mar 2018
Value US$981,682.90 | Price 10.14 | Shares 96,790
Buy 1 Mar 2018
Value US$4,243,284.53 | Price 10.33 | Shares 410,606
Buy 28 Feb 2018
Value US$213,928.00 | Price 10.70 | Shares 20,000
Planned sale 21 Feb 2018
Value US$17,498.80 | Price 10.67 | Shares 1,640
Planned sale 21 Feb 2018
Value US$11,822.36 | Price 10.67 | Shares 1,108
Planned sale 21 Feb 2018
Value US$13,678.94 | Price 10.67 | Shares 1,282
Planned sale 21 Feb 2018
Value US$49,146.02 | Price 10.67 | Shares 4,606
Buy 14 Feb 2018
Value US$103,487.15 | Price 10.96 | Shares 9,442
Buy 13 Feb 2018
Value US$6,118.69 | Price 10.97 | Shares 558
Buy 5 Jan 2018
Value US$575,500.00 | Price 11.51 | Shares 50,000
Buy 3 Jan 2018
Value US$163,353.00 | Price 10.89 | Shares 15,000
Buy 18 Dec 2017
Value US$1,057,493.06 | Price 11.13 | Shares 95,012
Sale 26 Sep 2017
Value US$18,324.54 | Price 15.99 | Shares 1,146
Sale 26 Sep 2017
Value US$57,180.24 | Price 15.99 | Shares 3,576
Sale 25 Sep 2017
Value US$14,391.00 | Price 15.99 | Shares 900
Planned sale 12 Jun 2017
Value US$44,480.98 | Price 21.53 | Shares 2,066
Sale 14 Mar 2017
Value US$81,839.82 | Price 26.58 | Shares 3,079
Sale 21 Feb 2017
Value US$9,991.64 | Price 22.76 | Shares 439
Sale 21 Feb 2017
Value US$23,351.76 | Price 22.76 | Shares 1,026
Sale 21 Feb 2017
Value US$38,600.96 | Price 22.76 | Shares 1,696
Planned sale 26 Jan 2017
Value US$24,012.18 | Price 16.78 | Shares 1,431
Planned sale 26 Jan 2017
Value US$11,662.10 | Price 16.78 | Shares 695
Planned sale 26 Jan 2017
Value US$24,012.18 | Price 16.78 | Shares 1,431
Sale 26 Jan 2017
Value US$13,105.18 | Price 16.78 | Shares 781
Sale 26 Jan 2017
Value US$8,742.38 | Price 16.78 | Shares 521
Sale 26 Jan 2017
Value US$16,024.90 | Price 16.78 | Shares 955
Buy 19 Dec 2016
Value US$6,750,000.00 | Price 13.50 | Shares 500,000
Buy 19 Dec 2016
Value US$6,750,000.00 | Price 13.50 | Shares 500,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-03-20 2019-03-20 S Sale
4.3
DUGGAN ROBERT W
Large shareholder
37,632 +2.1%
88.06
US$2,271,573 		37,632 +2.1% 88.06 US$2,271,573
2019-03-20 2019-03-19 S Sale
4.3
DUGGAN ROBERT W
Large shareholder
71,163 -7.3%
349.54
US$714,008 		71,163 -7.3% 349.54 US$714,008
2019-03-20 2019-03-18 S Sale
4.3
DUGGAN ROBERT W
Large shareholder
75,371 +13.5%
26.20
US$3,769,323 		75,371 +13.5% 26.20 US$3,769,323
2019-03-13 2019-03-13 S Sale
4.3
DUGGAN ROBERT W
Large shareholder
1,199,930 -14.9%
0.59
US$707,959 		1,199,930 -14.9% 0.59 US$707,959
2019-03-13 2019-03-12 S Sale
4.3
DUGGAN ROBERT W
Large shareholder
633,975 -7.3%
0.61
US$386,725 		633,975 -7.3% 0.61 US$386,725
2019-03-13 2019-03-11 S Sale
4.3
DUGGAN ROBERT W
Large shareholder
520,102 -5.7%
0.63
US$327,664 		520,102 -5.7% 0.63 US$327,664
2019-02-25 2019-02-21 S Sale
Bhatt Elizabeth

Chief Operating Officer

Officer
971 -0.4%
0.89
US$864 		971 -0.4% 0.89 US$864
2019-02-25 2019-02-21 S Sale
Dorling Janet

Chief Commercial Officer

Officer
1,063 -0.4%
0.89
US$946 		1,063 -0.4% 0.89 US$946
2019-02-25 2019-02-21 S Sale
Wise Blake

Chief Executive Officer

Officer
3,771 -0.7%
0.89
US$3,356 		3,771 -0.7% 0.89 US$3,356
2019-02-25 2019-02-21 S Sale
3.1
LOEB GARY

See Remarks

Officer
791 -0.3%
0.89
US$704 		791 -0.3% 0.89 US$704
2019-02-25 2019-02-21 S Sale
Sarpangal Zeryn

Chief Financial Officer

Officer
1,388 -0.6%
0.89
US$1,235 		1,388 -0.6% 0.89 US$1,235
2019-02-07 2019-02-05 S Sale
Dorling Janet

Chief Commercial Officer

Officer
818 -0.3%
1.35
US$1,104 		818 -0.3% 1.35 US$1,104
2018-12-12 2018-12-11 B Purchase DUGGAN ROBERT W Large shareholder
306,848 +3.5%
1.65
US$505,010 		306,848 +3.5% 1.65 US$505,010
2018-12-12 2018-12-10 B Purchase DUGGAN ROBERT W Large shareholder
436,500 +5.2%
1.60
US$697,789 		436,500 +5.2% 1.60 US$697,789
2018-12-11 2018-12-07 B Purchase DUGGAN ROBERT W Large shareholder
22,431 +0.3%
1.40
US$31,394 		22,431 +0.3% 1.40 US$31,394
2018-11-27 2018-11-27 B Purchase DUGGAN ROBERT W Large shareholder
77,585 +0.9%
1.68
US$129,963 		77,585 +0.9% 1.68 US$129,963
2018-11-27 2018-11-23 B Purchase DUGGAN ROBERT W Large shareholder
80,175 +1.0%
1.89
US$151,643 		80,175 +1.0% 1.89 US$151,643
2018-11-23 2018-11-20 B Purchase DUGGAN ROBERT W Large shareholder
231,495 +2.9%
1.93
US$446,947 		231,495 +2.9% 1.93 US$446,947
2018-11-20 2018-11-19 B Purchase DUGGAN ROBERT W Large shareholder
4,648 +0.1%
1.62
US$7,525 		4,648 +0.1% 1.62 US$7,525
2018-09-27 2018-09-25 S Sale
LOEB GARY

General Counsel

Officer
1,038 -4.3%
4.15
US$4,308 		1,038 -4.3% 4.15 US$4,308
2018-09-27 2018-09-25 S Sale Wise Blake

Chief Operating Officer

Officer
3,242 -3.4%
4.15
US$13,454 		3,242 -3.4% 4.15 US$13,454
2018-06-28 2018-06-26 PlS Planned sale
Dorling Janet

Chief Commercial Officer
450 -1.9%
9.59
US$4,316 		450 -1.9% 9.59 US$4,316
2018-06-28 2018-06-26 PlS Planned sale Wise Blake

Chief Executive Officer

Executive Director
1,194 -1.2%
9.59
US$11,450 		1,194 -1.2% 9.59 US$11,450
2018-06-28 2018-06-26 PlS Planned sale
Hillan Kenneth J.

See Remarks

Executive Director
744 -0.6%
9.59
US$7,135 		744 -0.6% 9.59 US$7,135
2018-06-28 2018-06-26 PlS Planned sale LOEB GARY

General Counsel
324 -1.3%
9.59
US$3,107 		324 -1.3% 9.59 US$3,107
2018-06-28 2018-06-26 S Sale Schilke Tobin

Chief Financial Officer
298 -0.6%
9.59
US$2,858 		298 -0.6% 9.59 US$2,858
2018-06-13 2018-06-11 PlS Planned sale Schilke Tobin

Chief Financial Officer
2,087 -4.2%
11.95
US$24,940 		2,087 -4.2% 11.95 US$24,940
2018-05-07 2018-05-03 B Purchase DUGGAN ROBERT W Large shareholder
100,255 +inf%
11.43
US$1,146,316 		100,255 +inf% 11.43 US$1,146,316
2018-05-07 2018-05-03 B Purchase DUGGAN ROBERT W Large shareholder
30,000 +inf%
11.54
US$346,338 		30,000 +inf% 11.54 US$346,338
2018-05-07 2018-05-03 B Purchase DUGGAN ROBERT W Large shareholder
846,625 +11.8%
11.31
US$9,579,477 		846,625 +11.8% 11.31 US$9,579,477
2018-04-27 2018-04-27 B Purchase DUGGAN ROBERT W Large shareholder
102,849 +1.5%
12.96
US$1,333,160 		102,849 +1.5% 12.96 US$1,333,160
2018-04-27 2018-04-26 B Purchase DUGGAN ROBERT W Large shareholder
50,000 +0.7%
12.96
US$647,755 		50,000 +0.7% 12.96 US$647,755
2018-04-27 2018-04-25 B Purchase DUGGAN ROBERT W Large shareholder
77,247 +1.1%
13.02
US$1,005,949 		77,247 +1.1% 13.02 US$1,005,949
2018-04-23 2018-04-23 B Purchase DUGGAN ROBERT W Large shareholder
132,487 +1.9%
13.07
US$1,730,969 		132,487 +1.9% 13.07 US$1,730,969
2018-04-23 2018-04-20 B Purchase DUGGAN ROBERT W Large shareholder
216,150 +3.3%
13.23
US$2,860,421 		216,150 +3.3% 13.23 US$2,860,421
2018-04-23 2018-04-19 B Purchase DUGGAN ROBERT W Large shareholder
119,700 +1.8%
12.76
US$1,527,264 		119,700 +1.8% 12.76 US$1,527,264
2018-04-04 2018-04-04 B Purchase DUGGAN ROBERT W Large shareholder
47,361 +0.7%
12.44
US$588,977 		47,361 +0.7% 12.44 US$588,977
2018-04-04 2018-04-03 B Purchase DUGGAN ROBERT W Large shareholder
24,100 +0.4%
12.46
US$300,240 		24,100 +0.4% 12.46 US$300,240
2018-04-04 2018-04-02 B Purchase DUGGAN ROBERT W Large shareholder
20,000 +0.3%
12.51
US$250,202 		20,000 +0.3% 12.51 US$250,202
2018-03-30 2018-03-28 B Purchase DUGGAN ROBERT W Large shareholder
30,000 +0.5%
12.44
US$373,095 		30,000 +0.5% 12.44 US$373,095
2018-03-21 2018-03-20 B Purchase DUGGAN ROBERT W Large shareholder
25,000 +0.4%
11.09
US$277,155 		25,000 +0.4% 11.09 US$277,155
2018-03-21 2018-03-19 B Purchase DUGGAN ROBERT W Large shareholder
11,300 +0.2%
11.20
US$126,557 		11,300 +0.2% 11.20 US$126,557
2018-03-16 2018-03-15 B Purchase DUGGAN ROBERT W Large shareholder
30,000 +0.5%
11.23
US$336,756 		30,000 +0.5% 11.23 US$336,756
2018-03-16 2018-03-14 B Purchase DUGGAN ROBERT W Large shareholder
19,660 +0.3%
11.57
US$227,488 		19,660 +0.3% 11.57 US$227,488
2018-03-15 2018-03-13 S Sale Hillan Kenneth J.

See Remarks

Executive Director
2,735 -2.8%
11.74
US$32,109 		2,735 -2.8% 11.74 US$32,109
2018-03-13 2018-03-12 B Purchase DUGGAN ROBERT W Large shareholder
20,000 +0.3%
11.39
US$227,802 		20,000 +0.3% 11.39 US$227,802
2018-03-13 2018-03-09 B Purchase DUGGAN ROBERT W Large shareholder
50,000 +0.8%
11.41
US$570,520 		50,000 +0.8% 11.41 US$570,520
2018-03-02 2018-03-02 B Purchase DUGGAN ROBERT W Large shareholder
96,790 +1.6%
10.14
US$981,683 		96,790 +1.6% 10.14 US$981,683
2018-03-02 2018-03-01 B Purchase DUGGAN ROBERT W Large shareholder
410,606 +7.2%
10.33
US$4,243,285 		410,606 +7.2% 10.33 US$4,243,285
2018-03-02 2018-02-28 B Purchase DUGGAN ROBERT W Large shareholder
20,000 +0.4%
10.70
US$213,928 		20,000 +0.4% 10.70 US$213,928
2018-02-23 2018-02-21 PlS Planned sale
Wise Blake

Chief Executive Officer

Executive Director
1,640 -2.4%
10.67
US$17,499 		1,640 -2.4% 10.67 US$17,499
2018-02-23 2018-02-21 PlS Planned sale
3.8
Schilke Tobin

Chief Financial Officer

Officer
1,108 -2.7%
10.67
US$11,822 		1,108 -2.7% 10.67 US$11,822
2018-02-23 2018-02-21 PlS Planned sale Swem Lee

Chief Scientific Officer

Officer
1,282 -3.4%
10.67
US$13,679 		1,282 -3.4% 10.67 US$13,679
2018-02-23 2018-02-21 PlS Planned sale Hillan Kenneth J.

See Remarks

Executive Director
4,606 -4.5%
10.67
US$49,146 		4,606 -4.5% 10.67 US$49,146
2018-02-15 2018-02-14 B Purchase DUGGAN ROBERT W Large shareholder
9,442 +0.2%
10.96
US$103,487 		9,442 +0.2% 10.96 US$103,487
2018-02-15 2018-02-13 B Purchase DUGGAN ROBERT W Large shareholder
558 +0.0%
10.97
US$6,119 		558 +0.0% 10.97 US$6,119
2018-01-05 2018-01-05 B Purchase DUGGAN ROBERT W Large shareholder
50,000 +0.9%
11.51
US$575,500 		50,000 +0.9% 11.51 US$575,500
2018-01-05 2018-01-03 B Purchase DUGGAN ROBERT W Large shareholder
15,000 +0.3%
10.89
US$163,353 		15,000 +0.3% 10.89 US$163,353
2017-12-20 2017-12-18 B Purchase DUGGAN ROBERT W Large shareholder
95,012 +1.7%
11.13
US$1,057,493 		95,012 +1.7% 11.13 US$1,057,493
2017-09-28 2017-09-26 S Sale
LOEB GARY

General Counsel
1,146 -7.9%
15.99
US$18,325 		1,146 -7.9% 15.99 US$18,325
2017-09-28 2017-09-26 S Sale
Wise Blake

President & COO
3,576 -5.1%
15.99
US$57,180 		3,576 -5.1% 15.99 US$57,180
2018-05-15 2017-09-25 S Sale Swem Lee

Chief Scientific Officer

Officer
900 -2.4%
15.99
US$14,391 		900 -2.4% 15.99 US$14,391
2017-06-14 2017-06-12 PlS Planned sale
3.8
Schilke Tobin

Chief Financial Officer
2,066 -4.9%
21.53
US$44,481 		2,066 -4.9% 21.53 US$44,481
2017-03-16 2017-03-14 S Sale
Hillan Kenneth J.

Chief Executive Officer

Executive Director
3,079 -3.0%
26.58
US$81,840 		3,079 -3.0% 26.58 US$81,840
2017-02-23 2017-02-21 S Sale Sarpangal Zeryn

See Remarks
439 -2.6%
22.76
US$9,992 		439 -2.6% 22.76 US$9,992
2017-02-23 2017-02-21 S Sale Friedland Ian

SVP, Chief Medical Officer
1,026 -2.7%
22.76
US$23,352 		1,026 -2.7% 22.76 US$23,352
2017-02-23 2017-02-21 S Sale
Hillan Kenneth J.

Chief Executive Officer

Executive Director
1,696 -2.7%
22.76
US$38,601 		1,696 -2.7% 22.76 US$38,601
2017-01-30 2017-01-26 PlS Planned sale
Hillan Kenneth J.

Chief Executive Officer

Executive Director
1,431 -2.2%
16.78
US$24,012 		1,431 -2.2% 16.78 US$24,012
2017-01-30 2017-01-26 PlS Planned sale Friedland Ian

Chief Medical Officer
695 -1.8%
16.78
US$11,662 		695 -1.8% 16.78 US$11,662
2017-01-30 2017-01-26 PlS Planned sale
Wise Blake

Chief Operating Officer
1,431 -3.0%
16.78
US$24,012 		1,431 -3.0% 16.78 US$24,012
2017-01-30 2017-01-26 S Sale
Sarpangal Zeryn

VP, HR and Corporate Affairs
781 -4.4%
16.78
US$13,105 		781 -4.4% 16.78 US$13,105
2017-01-30 2017-01-26 S Sale
LOEB GARY

General Counsel
521 -3.5%
16.78
US$8,742 		521 -3.5% 16.78 US$8,742
2017-01-30 2017-01-26 S Sale Schilke Tobin

Chief Financial Officer
955 -3.5%
16.78
US$16,025 		955 -3.5% 16.78 US$16,025
2016-12-19 2016-12-19 B Purchase MOTT DAVID M Large shareholder
500,000 +10.6%
13.50
US$6,750,000 		500,000 +10.6% 13.50 US$6,750,000
2016-12-19 2016-12-19 B Purchase Sonsini Peter W. Large shareholder
500,000 +10.6%
13.50
US$6,750,000 		500,000 +10.6% 13.50 US$6,750,000
Explore more

More insider trading research around Achaogen Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America